Trading a DFTX straddle lets you take a pure volatility position on Definium Therapeutics Inc without committing to a direction. Definium Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate DFTX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on DFTX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Definium Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the DFTX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Definium Therapeutics, Inc. is a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the DFTX straddle is the cleanest expression of that view. Our scanner prices every DFTX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a DFTX straddle into a catalyst or short a DFTX straddle to harvest decay, the options straddle setups that matter are all in one place.
